Cargando…

Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016

IMPORTANCE: The Centers for Disease Control and Prevention guidelines in 2016 recommended avoiding concurrent use of opioids and benzodiazepines. OBJECTIVE: To determine whether the release of the guidelines was associated with changes in coprescription of opioids and benzodiazepines. DESIGN, SETTIN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeffery, Molly M., Hooten, W. Michael, Jena, Anupam B., Ross, Joseph S., Shah, Nilay D., Karaca-Mandic, Pinar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681551/ https://www.ncbi.nlm.nih.gov/pubmed/31373650 http://dx.doi.org/10.1001/jamanetworkopen.2019.8325

Ejemplares similares

Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors
por: Togun, Adeniyi T., et al.
Publicado: (2021)

The growing problem of co-treatment with opioids and benzodiazepines
por: Karaca-Mandic, Pinar, et al.
Publicado: (2017)

Opioid stewardship: implementing a proactive, pharmacist-led intervention for patients coprescribed opioids and benzodiazepines at an urban academic primary care centre
por: Tilli, Tiana, et al.
Publicado: (2020)

Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration
por: Sankar, Ashwini, et al.
Publicado: (2021)

Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices
por: Togun, Adeniyi T, et al.
Publicado: (2021)

Adherence to coprescribing of laxatives with opioids and associated characteristics in general practices in the Netherlands
por: Hek, Karin, et al.
Publicado: (2022)

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
por: Jena, Anupam B, et al.
Publicado: (2014)

Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial
por: Vu, Khoa, et al.
Publicado: (2021)

Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs
por: Chang, Jessica, et al.
Publicado: (2023)

Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain
por: Goldstick, Jason E., et al.
Publicado: (2021)

State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain
por: Lyu, Xiru, et al.
Publicado: (2023)

Patterns in Nonopioid Pain Medication Prescribing After the Release of the 2016 Guideline for Prescribing Opioids for Chronic Pain
por: Goldstick, Jason E., et al.
Publicado: (2022)

Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance
por: Jeffery, Molly Moore, et al.
Publicado: (2020)

Association of the 2016 US Centers for Disease Control and Prevention Opioid Prescribing Guideline With Changes in Opioid Dispensing After Surgery
por: Sutherland, Tori N., et al.
Publicado: (2021)

Association Between Preoperative Benzodiazepine Use and Postoperative Opioid Use and Health Care Costs
por: Rishel, Chris A., et al.
Publicado: (2020)

Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017
por: Tori, Marco E., et al.
Publicado: (2020)

Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2021)

Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries
por: Hernandez, Inmaculada, et al.
Publicado: (2018)

Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Association of New Perioperative Benzodiazepine Use With Persistent Benzodiazepine Use
por: Wright, Jason D., et al.
Publicado: (2021)

Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings
por: Suvada, Kara, et al.
Publicado: (2022)

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
por: Jeffery, Molly Moore, et al.
Publicado: (2018)

Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand
por: Rattanachotphanit, Thananan, et al.
Publicado: (2019)

Assessment of Care Handoffs Among Hospitalist Physicians and 30-Day Mortality in Hospitalized Medicare Beneficiaries
por: Farid, Monica, et al.
Publicado: (2021)

Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015
por: Xu, Kevin Y., et al.
Publicado: (2020)

Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits
por: Gwee, Kok Ann, et al.
Publicado: (2018)

Polysubstance Abuse: Alcohol, Opioids and Benzodiazepines Require Coordinated Engagement by Society, Patients, and Physicians
por: Ogbu, Uzor C., et al.
Publicado: (2015)

Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances
por: Chen, Alice, et al.
Publicado: (2018)

US Trends in COVID-19–Associated Hospitalization and Mortality Rates Before and After Reopening Economies
por: Gupta, Sumedha, et al.
Publicado: (2021)

Effect of Pharmacist Email Alerts on Concurrent Prescribing of Opioids and Benzodiazepines by Prescribers and Primary Care Managers: A Randomized Clinical Trial
por: Sacarny, Adam, et al.
Publicado: (2022)

Associations of Maternal Use of Benzodiazepines or Benzodiazepine-like Hypnotics During Pregnancy With Immediate Pregnancy Outcomes in Norway
por: Huitfeldt, Anders, et al.
Publicado: (2020)

Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines
por: Jones, Christopher M., et al.
Publicado: (2023)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Assessment of Changes in the Geographical Distribution of Opioid-Related Mortality Across the United States by Opioid Type, 1999-2016
por: Kiang, Mathew V., et al.
Publicado: (2019)

Patterns in Outpatient Benzodiazepine Prescribing in the United States
por: Agarwal, Sumit D., et al.
Publicado: (2019)

Opioid and non-opioid analgesic prescribing before and after the CDC’s 2016 opioid guideline
por: Encinosa, William, et al.
Publicado: (2021)

Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention’s Opioid Prescribing Guidelines
por: Scherrer, Jeffrey F., et al.
Publicado: (2020)

A comparison of opioids and benzodiazepines dispensing in Australia
por: Islam, M. Mofizul, et al.
Publicado: (2019)

Characteristics of Hydroxychloroquine Dispensing in the United States, January to May 2020
por: Levin, Zachary, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6si0bgsrrhcjoojqogc9k8qimr